These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9252802)

  • 1. Myasthenia gravis following IFN-alpha-2a treatment.
    Bora I; Karli N; Bakar M; Zarifoğlu M; Turan F; Oğul E
    Eur Neurol; 1997; 38(1):68. PubMed ID: 9252802
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis.
    Mase G; Zorzon M; Biasutti E; Vitrani B; Cazzato G; Urban F; Frezza M
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):348-9. PubMed ID: 8609521
    [No Abstract]   [Full Text] [Related]  

  • 3. Exacerbation of myasthenia gravis during interferon-alpha treatment.
    Uyama E; Fujiki N; Uchino M
    J Neurol Sci; 1996 Dec; 144(1-2):221-2. PubMed ID: 8994129
    [No Abstract]   [Full Text] [Related]  

  • 4. Myasthenia gravis during interferon alfa therapy.
    Batocchi AP; Evoli A; Servidei S; Palmisani MT; Apollo F; Tonali P
    Neurology; 1995 Feb; 45(2):382-3. PubMed ID: 7854543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis induced by alpha-interferon therapy.
    Pérez A; Perella M; Pastor E; Cano M; Escudero J
    Am J Hematol; 1995 Aug; 49(4):365-6. PubMed ID: 7639296
    [No Abstract]   [Full Text] [Related]  

  • 6. Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.
    Piccolo G; Franciotta D; Versino M; Alfonsi E; Lombardi M; Poma G
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):348. PubMed ID: 8609520
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
    Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
    [No Abstract]   [Full Text] [Related]  

  • 8. Pegylated interferon induced myasthenia crisis--a case report.
    Congeni JP; Kirkpatrick RB
    J Clin Neuromuscul Dis; 2013 Mar; 14(3):123-5. PubMed ID: 23492465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oculo-bulbar myasthenia gravis induced by cytokine treatment of a patient with metastasized renal cell carcinoma.
    Rohde D; Sliwka U; Schweizer K; Jakse G
    Eur J Clin Pharmacol; 1996; 50(6):471-3. PubMed ID: 8858274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy.
    Oishi A; Miyamoto K; Kashii S; Yoshimura N
    Br J Ophthalmol; 2005 Nov; 89(11):1542-3. PubMed ID: 16234478
    [No Abstract]   [Full Text] [Related]  

  • 11. [Myasthenia during interferon alpha therapy].
    Quilichini R; Mazzerbo F; Baume D; Amiel O; Lafeuillade A; Pellegrino P
    Presse Med; 1995 Sep 2-9; 24(25):1178. PubMed ID: 7567837
    [No Abstract]   [Full Text] [Related]  

  • 12. Myasthenia gravis after interferon-alpha treatment.
    Lensch E; Faust J; Nix WA; Wandel E
    Muscle Nerve; 1996 Jul; 19(7):927-8. PubMed ID: 8965856
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.
    Kang HM; Park MJ; Hwang JM; Kim JW; Jeong SH
    Korean J Hepatol; 2009 Jun; 15(2):209-15. PubMed ID: 19581773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sarcoidosis, myasthenia gravis and anterior ischaemic optic neuropathy: severe side effects of adjuvant interferon-alpha-therapy in malignant melanoma?].
    Kreutzer K; Bonnekoh B; Franke I; Ulrich J; Gollnick H
    J Dtsch Dermatol Ges; 2004 Aug; 2(8):689-94. PubMed ID: 16279234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peginterferon and ribavirin for hepatitis C.
    Evoli A; Servidei S
    N Engl J Med; 2007 Mar; 356(12):1269-70; author reply 1271. PubMed ID: 17380575
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins can induce myasthenia gravis.
    Gale J; Danesh-Meyer HV
    J Clin Neurosci; 2014 Feb; 21(2):195-7. PubMed ID: 24433954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of thymoma-associated myasthenia gravis with antibodies against interferon-alpha--a clinico-immunological follow up of the symptoms and its titer].
    Nakamori M; Matsumura T; Saito T; Kunitomi A; Iyama A; Nozaki S; Fujimura H; Shinno S
    Rinsho Shinkeigaku; 2003 Sep; 43(9):544-7. PubMed ID: 14727560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies to interferon alpha in a chronic hepatitis C patient non-responder to pegylated interferon.
    Santantonio T; Milella M; Antonelli G; Scagnolari C
    J Hepatol; 2006 Nov; 45(5):759-61. PubMed ID: 16979777
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of the immunoreactivity of anti-interferon alpha antibodies in myasthenia gravis patients. Epitope mapping.
    Bello-Rivero I; Cervantes M; Torres Y; Ferrero J; Rodríguez E; Pérez J; García I; Díaz G; López-Saura P
    J Autoimmun; 2004 Aug; 23(1):63-73. PubMed ID: 15236754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C.
    Borgia G; Reynaud L; Gentile I; Cerini R; Ciampi R; Dello Russo M; Piazza M
    J Interferon Cytokine Res; 2001 Jul; 21(7):469-70. PubMed ID: 11506739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.